There are significant clinical consequences to patients with heart failure if they are undertreated. Evidence clearly shows that with optimal guideline-directed care, life expectancy and quality of life can substantially improve. We can do better. Will you join us?
Improving Care of Heart Failure in the EU: Voices of the GHFA Steering Committee

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
There are significant clinical consequences to patients with heart failure if they are undertreated. Evidence clearly shows that with optimal guideline-directed care, life expectancy and quality of life can substantially improve. We can do better. Will you join us?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Second-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?